drugset / Trial / NCT05509946

Preemptive Analgesia Combination of Celecoxib and Pregabalin in THA

NCT05509946

Phase 2/3 Unknown 30 enrolled Indonesia University
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a double-blinded randomized controlled trial aims to evaluate the effect of preemptive analgetic combination of celecoxib and pregabalin to acute pain after total hip arthroplasty. This study will be conducted in Cipto Mangunkusumo Hospital, Jakarta, Indonesia, from October 2022 to April 2023. The subject of this study is adult patient who will be performed total hip arthroplasty.

Timeline

Start
2022-10-01
Primary completion
2023-04-01
Completion
2023-04-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg
Subject Celecoxib Other / unclassified 400 mg
Subject Pregabalin Small molecule 75 mg
Subject Pregabalin Small molecule 150 mg

Indications

No indication recorded.